AOK BAVARIA - THE HEALTH INSURANCE COMPANY has floated a tender for Open House Drug Rebate Agreements Everolimus, Atc L04aa18 and Everolimus as Off-Patent Oncology Indications not Related to Tuberous Sclerosis (Tsc), Atc L01eg02. The project location is Germany and the tender is closing on 05 Jan 2025. The tender notice number is -, while the TOT Ref Number is 77508900.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Open House Drug Rebate Agreements Everolimus, Atc L04aa18 and Everolimus as Off-Patent Oncology Indications not Related to Tuberous Sclerosis (Tsc), Atc L01eg02
Sign in with Google